Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology

Venous thromboembolism (VTE) is a common complication in patients with cancer. About 15% of patients with cancer experience one or more episodes of acute VTE during the course of their disease, while about 20% of patients with acute VTE have cancer at the time of the thromboembolic event [1–3].